E-MTAB-1627 - RNA-seq of coding RNA of human tumour Calu6 and LoVo xenografts with the VEGFR tyrosine kinase inhibitor cediranib to investigate mRNA expression changes induced by treatment
Released on 9 September 2013, last updated on 3 May 2014
Calu6 and LoVo xenograft mRNA expression profiles in response to cediranib treatment
RNA-seq of coding RNA, co-expression, compound treatment human tumour xenografts with the VEGFR tyrosine kinase inhibitor cediranib , in vivo
RNA-Seq differentiates tumour and host mRNA expression changes induced by treatment of human tumour xenografts with the VEGFR tyrosine kinase inhibitor cediranib. James R. Bradford, Matthew Farren, Steve J. Powell, Sarah Runswick, Susie L. Weston, Helen Brown, Oona Delpuech, Mark Wappett1 Neil R. Smith, T. Hedley Carr, Jonathan R. Dry, Neil J. Gibson and Simon T. Barry.
RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib. Bradford JR, Farren M, Powell SJ, Runswick S, Weston SL, Brown H, Delpuech O, Wappett M, Smith NR, Carr TH, Dry JR, Gibson NJ, Barry ST. :e66003 (2013), Europe PMC 23840389